Comments, Suggestions and Criticisms of the PRECIS-2 Design Tool: A Citation Analysis.


Journal

Journal of clinical epidemiology
ISSN: 1878-5921
Titre abrégé: J Clin Epidemiol
Pays: United States
ID NLM: 8801383

Informations de publication

Date de publication:
14 Sep 2024
Historique:
received: 19 07 2024
revised: 02 09 2024
accepted: 09 09 2024
medline: 17 9 2024
pubmed: 17 9 2024
entrez: 16 9 2024
Statut: aheadofprint

Résumé

The Pragmatic Explanatory Continuum Indicator Summary (PRECIS) tool, initially published in 2009 and revised in 2015, was created to assist trialists to align their design choices with the intended purpose of their randomised controlled trial (RCT): either to guide real-world decisions between alternative interventions (pragmatic) or to test hypotheses about intervention mechanisms by minimising sources of variation (explanatory). There have been many comments, suggestions and criticisms of PRECIS-2. This summary will be used to facilitate the development of to the next revision, PRECIS-3. We used Web of Science to identify all publication types citing PRECIS-2, published between May 2015 and July 2023. Citations were eligible if they contained 'substantive' suggestions, comments or criticism of the PRECIS-2 tool. We defined 'substantive' as comments explicitly referencing at least one PRECIS-2 domain, or a concept directly linked to an existing or newly proposed domain Two reviewers independently extracted comments, suggestions and criticisms, noting their implications for the update. These were discussed amongst authors to achieve consensus on the interpretation of each comment and its implications for PRECIS-3. The search yielded 885 publications, and after full-text review, 89 articles met the inclusion criteria. Comments pertained to new domains, changes in existing domains, or were relevant across several or all domains. Proposed new domains included assessment of the comparator arm and a domain to describe blinding. There were concerns about scoring eligibility and recruitment domains for cluster trials. Suggested areas for improvement across domains included the need for more scoring guidance for explanatory design choices. Published comments recognise PRECIS-2's success in aiding trialists with pragmatic or explanatory design choices. Enhancing its implementation and widespread use will involve adding new domains, refining domain definitions, and addressing overall tool issues. This citation review offers valuable user feedback, pivotal for shaping the upcoming version of the PRECIS tool, PRECIS-3.

Identifiants

pubmed: 39284517
pii: S0895-4356(24)00290-7
doi: 10.1016/j.jclinepi.2024.111534
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

111534

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Auteurs

Andrew Willis (A)

HRB Clinical Research Facility, University College Cork, Ireland; School of Public Health, University College Cork, Ireland. Electronic address: awillis@ucc.ie.

Frances Shiely (F)

HRB Clinical Research Facility, University College Cork, Ireland; School of Public Health, University College Cork, Ireland.

Shaun Treweek (S)

Health Services Research Unit, University of Aberdeen, AB25 2ZD, UK.

Monica Taljaard (M)

Ottawa Hospital Research Institute, Clinical Epidemiology Program, Centre for Practice-Changing Research, The Ottawa Hospital, Ottawa, Ontario K1H 8L6, Canada; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.

Kirsty Loudon (K)

Independent Researcher.

Alison Howie (A)

Western Centre for Public Health and Family Medicine, 1465 Richmond St., London, Ontario N6G 2M1, Canada.

Merrick Zwarenstein (M)

Centre for Studies in Family Medicine, Depts of Family Medicine and Epidemiology/Biostatistics, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.

Classifications MeSH